Bio-Works Technologies
Bio-Works Receives Two WorkBeads 100S and 100Q Orders Worth SEK 4 Million
The deliveries are scheduled for Q1-Q2 2026 and strengthen the company's order book for the coming year.
The orders confirm the growing demand for Bio-Works' scalable and cost-efficient affinity solutions for biopharmaceutical manufacturing.
"This transaction demonstrates both the strength of our long-term customer relationships and the increasing global demand for our WorkBeads products. It supports our planned growth and aligns well with our ambition to build a profitable and scalable Bio-Works," says Lone Carlbom, CEO of Bio-Works.
This disclosure contains information that Bio-Works Technologies AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 29-12-2025 08:00 CET.
| Datum | 2025-12-29, kl 08:00 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!